Christine Fox, who most recently served as global president of gene therapies at Novartis, will head Teva’s U.S. commercial business, succeeding Sven Dethlefs.
Arformoterol Tartrate Inhalation Solution is indicated for long-term, twice-daily administration in the maintenance treatment of bronchoconstriction in patients with COPD.